Integra LifeSciences (IART) –
-
Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024
-
Integra LifeSciences (IART) PT Lowered to $37 at Truist Securities
-
Form ARS INTEGRA LIFESCIENCES For: Dec 31
-
Form DEF 14A INTEGRA LIFESCIENCES For: Dec 31
-
Citi Upgrades Integra LifeSciences (IART) to Neutral
-
Integra LifeSciences (IART) Completes Acquisition of Acclarent
-
Integra LifeSciences Completes the Acquisition of Acclarent, Inc.
-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Integra Lifesciences Holdings Corp - IART
-
Form PRE 14A INTEGRA LIFESCIENCES For: Dec 31
-
Form 4 INTEGRA LIFESCIENCES For: Mar 11 Filed by: De Witte Jan
-
Form 4 INTEGRA LIFESCIENCES For: Mar 11 Filed by: DAVIS ROBERT T. JR.
-
Form 4 INTEGRA LIFESCIENCES For: Mar 11 Filed by: McBreen Michael J.
-
Form 4 INTEGRA LIFESCIENCES For: Mar 11 Filed by: Veillon-Berteloot Chantal
-
Form 4 INTEGRA LIFESCIENCES For: Mar 11 Filed by: Schwartz Eric
-
Form 4 INTEGRA LIFESCIENCES For: Mar 11 Filed by: Knight Lea Daniels
-
Form 4 INTEGRA LIFESCIENCES For: Mar 11 Filed by: Singh Harvinder
-
Form 4 INTEGRA LIFESCIENCES For: Mar 11 Filed by: Mosebrook Jeffrey
-
Form 4 INTEGRA LIFESCIENCES For: Mar 10 Filed by: DAVIS ROBERT T. JR.
-
Form 4 INTEGRA LIFESCIENCES For: Mar 10 Filed by: McBreen Michael J.
-
Form 4 INTEGRA LIFESCIENCES For: Mar 10 Filed by: Schwartz Eric
-
Form 4 INTEGRA LIFESCIENCES For: Mar 10 Filed by: Mosebrook Jeffrey
-
Form 4 INTEGRA LIFESCIENCES For: Mar 10 Filed by: De Witte Jan
-
Form 4 INTEGRA LIFESCIENCES For: Mar 10 Filed by: Singh Harvinder
-
Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases
-
Form 4 INTEGRA LIFESCIENCES For: Mar 06 Filed by: DAVIS ROBERT T. JR.
-
Form 144 INTEGRA LIFESCIENCES Filed by: DAVIS ROBERT T. JR.
-
Integra LifeSciences (IART) PT Lowered to $41 at Truist Securities, 'the company will need to demonstrate several quarters of execution'
-
Integra LifeSciences (IART) PT Lowered to $45 at Wells Fargo
-
Integra LifeSciences (IART) PT Lowered to $49 at JMP Securities
-
Form 10-K INTEGRA LIFESCIENCES For: Dec 31
-
Form 8-K INTEGRA LIFESCIENCES For: Feb 27
-
Integra LifeSciences (IART) Misses Q4 EPS by 1c, provides guidance
-
Form 8-K INTEGRA LIFESCIENCES For: Feb 28
-
Integra LifeSciences (IART) Announces Resignation of Jan De Witte
-
Integra LifeSciences Announces Leadership Transition Plan
-
Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
-
Form 8-K/A INTEGRA LIFESCIENCES For: Dec 12
-
Form 4 INTEGRA LIFESCIENCES For: Feb 20 Filed by: McBreen Michael J.
-
Form 4 INTEGRA LIFESCIENCES For: Feb 20 Filed by: Mosebrook Jeffrey
-
Form 4 INTEGRA LIFESCIENCES For: Feb 20 Filed by: Schwartz Eric
-
Form 4 INTEGRA LIFESCIENCES For: Feb 20 Filed by: DAVIS ROBERT T. JR.
-
Form SC 13G/A INTEGRA LIFESCIENCES Filed by: VANGUARD GROUP INC
-
Form SC 13G/A INTEGRA LIFESCIENCES Filed by: Champlain Investment Partners, LLC
-
Form SC 13G INTEGRA LIFESCIENCES Filed by: Capital Research Global Investors
-
Form SC 13G/A INTEGRA LIFESCIENCES Filed by: MORGAN STANLEY
-
Form SC 13G/A INTEGRA LIFESCIENCES Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024
-
Form SC 13G/A INTEGRA LIFESCIENCES Filed by: BlackRock Inc.
-
Form 4 INTEGRA LIFESCIENCES For: Jan 18 Filed by: De Witte Jan
-
Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Back to IART Stock Lookup